These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16083099)

  • 1. Pharma's commitment to maintaining a clinical trial register: increased transparency or contrived public appeasement?
    Falit B
    J Law Med Ethics; 2005; 33(2):391-6. PubMed ID: 16083099
    [No Abstract]   [Full Text] [Related]  

  • 2. Big Pharma's Commedia.
    Steele FR
    Cell; 2005 Dec; 123(6):971-3. PubMed ID: 16360023
    [No Abstract]   [Full Text] [Related]  

  • 3. Drugmakers prefer silence on test data; firms violate US law by not registering trials.
    Vedantam S
    Washington Post; 2004 Jul; ():A1, A4. PubMed ID: 15290815
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trials transparency and the Trial and Experimental Studies Transparency (TEST) act.
    Logvinov I
    Contemp Clin Trials; 2014 Mar; 37(2):219-24. PubMed ID: 24440100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharma's year of trouble and strife.
    Frantz S
    Nat Rev Drug Discov; 2006 Jan; 5(1):7-9. PubMed ID: 16485339
    [No Abstract]   [Full Text] [Related]  

  • 6. Predictable materiality: a need for common criteria governing the disclosure of clinical trial results by publicly-traded pharmaceutical companies.
    Cohen K; Cormier JW; Davar MV
    J Contemp Health Law Policy; 2013; 29(2):201-32. PubMed ID: 23837261
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug giants fail to name compounds in trial database.
    Wadman M
    Nature; 2005 Jun; 435(7042):548. PubMed ID: 15931185
    [No Abstract]   [Full Text] [Related]  

  • 8. Investment managers back greater transparency of clinical trials.
    Hawkes N
    BMJ; 2015 Jul; 351():h4002. PubMed ID: 26207007
    [No Abstract]   [Full Text] [Related]  

  • 9. Spitzer sues drug giant for deceiving doctors.
    Wadman M
    Nature; 2004 Jun; 429(6992):589. PubMed ID: 15190317
    [No Abstract]   [Full Text] [Related]  

  • 10. IT solutions for big Pharma's big headache.
    Krohn R
    J Healthc Inf Manag; 2005; 19(1):13-5. PubMed ID: 15682670
    [No Abstract]   [Full Text] [Related]  

  • 11. Glaxo agrees to post results of drug trials on web site.
    Harris G
    N Y Times Web; 2004 Aug; ():C4. PubMed ID: 15540364
    [No Abstract]   [Full Text] [Related]  

  • 12. Investing in risk management.
    Fiscus PW
    Nat Biotechnol; 1997 Jan; 15(1):88-9. PubMed ID: 9035113
    [No Abstract]   [Full Text] [Related]  

  • 13. Despite vow, drug makers still withhold data.
    Berenson A
    N Y Times Web; 2005 May; ():A1, C3. PubMed ID: 15952254
    [No Abstract]   [Full Text] [Related]  

  • 14. Expose your clinical thinking.
    Nat Biotechnol; 2004 Aug; 22(8):927. PubMed ID: 15286628
    [No Abstract]   [Full Text] [Related]  

  • 15. Transparent reaction. Suppliers oppose FDA move to disclose more data.
    Rhea S
    Mod Healthc; 2010 Jul; 40(30):16. PubMed ID: 20695055
    [No Abstract]   [Full Text] [Related]  

  • 16. Results of drug trials can mystify doctors through omission: some professional groups demand public listing of all test outcomes.
    Meier B
    N Y Times Web; 2004 Jul; ():C1, C3. PubMed ID: 15290807
    [No Abstract]   [Full Text] [Related]  

  • 17. Neonatal drug trials: impact of EU and US paediatric regulations.
    Pansieri C; Bonati M; Choonara I; Jacqz-Aigrain E
    Arch Dis Child Fetal Neonatal Ed; 2014 Sep; 99(5):F438. PubMed ID: 24792777
    [No Abstract]   [Full Text] [Related]  

  • 18. A critique of emerging European legislation in the pharmaceutical industry: a clinical trials analysis.
    Murray E; McAdam R; Burke MT
    Int J Health Care Qual Assur Inc Leadersh Health Serv; 2004; 17(7):389-93. PubMed ID: 15552394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial data as a public good.
    Rodwin MA; Abramson JD
    JAMA; 2012 Sep; 308(9):871-2. PubMed ID: 22948695
    [No Abstract]   [Full Text] [Related]  

  • 20. ASHP, other groups, advise FDA about solving counterfeit drug problems.
    Young D
    Am J Health Syst Pharm; 2003 Dec; 60(23):2406, 2408, 2411. PubMed ID: 14686215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.